Cerebral radionecrosis in an adult
Journal: Advances in Medicine and Engineering Interdisciplinary Research DOI: 10.32629/ameir.v3i4.4857
Abstract
The case report of a 37-year-old patient with history of having received radiotherapy due to a tumor lesion in the right frontal region is presented, who attended to the Institute of Neurology and Neurosurgery in Cuba because of intense headache and left hemiparesis. After carrying out the necessary examinations, the clinical-imaging diagnosis of a radionecrosis lesion in the contralateral hemisphere was established, which was corroborated in the pathological examination once the tumor was removed; then, immunotherapy was indicated. The patient had a favorable clinical course because the control of the disease was achieved as well as the resolution of symptoms.
Keywords
cerebral ventricle neoplasm; glioma; central nervous system; radionecrosis; radiotherapy; immunotherapy
Full Text
PDF - Viewed/Downloaded: 0 TimesReferences
[1] Ellingson BM, Chung C, Pope WB, Boxerman JL, Kaufmann TJ. Pseudoprogression, radionecrosis, inflammation or true tumor progression? Challenges associated with glioblastoma response assessment in an evolving therapeutic landscape. J Neurooncol. 2017 [citado 12/05/2023];134(3):495–504. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893814/.
[2] Wernicke AG, Taube S, Smith AW, Herskovic A, Parashar B, Schwartz TH. Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control. Brachytherapy. 2020 [citado 12/05/2023];19(5):705-12. Disponible en https://www.sciencedirect.com/science/article/abs/pii/S1538472120301318?via%3D ihub.
[3] Chung C, Bryant A, Brown PD. Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery. Cochrane Database of Systematic Reviews. 2018 [citado 12/05/2023];7(7):CD011492. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513335/.
[4] Raggabi A, Bourazza A, Lalya I. Prise en charge de la radionécrose cérébrale: expérience du Service de Neurologie de l'Hôpital Militaire d'Instruction Mohammed V. Pan Afr Med J. 2019 [citado 12/05/2023];33. Disponible en: https://www.panafrican- med-journal.com/content/article/33/188/full/.
[5] Donovan EK, Parpia S, Greenspoon JN. Incidence of radionecrosis in single-fraction radiosurgery compared with fractionated radiotherapy in the treatment of brain metastasis. Curr Oncol. 2019 [citado 12/05/2023];26(3):e328-e33. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588068/.
[6] Lupattelli M, Alì E, Ingrosso G, Saldi S, Fulcheri C, Borghesi S, et al. Stereotactic Radiotherapy for Brain Metastases: Imaging Tools and Dosimetric Predictive Factors for Radionecrosis. J Pers Med. 2020 [citado 12/05/2023];10(3):59. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565332/pdf/jpm-10-00059.pdf.
[7] Rascón Ramírez FJ, Sallabanda Díaz K, Salazar Ascencio OA, Trondin A, Avecillas Chasín JM. Radionecrosis gigante recurrente imitando un glioma de alto grado: el uso de ácido 5-aminolevulínico como técnica para su diferenciación. Gliomat. 2015 [citado 12/05/2023];1(3):51-3. Disponible en: https://www.researchgate.net/publication/297038197_Radionecrosis_recurrente_imit ando_glioma_de_alto_el_uso_de_5-aminolevulinico_como_tecnica_para_su_diferenciacion.
[8] Erpolat OP, Demircan NV, Sarıbas GS, Kuzucu P, Senturk E, Elmas C, et al. A Comparison of Ramipril and Bevacizumab to Mitigate Radiation-Induced Brain Necrosis: An Experimental Study. World Neurosurg. 2020 [citado 12/05/2023];144:e210-e20. Disponible en:https://www.sciencedirect.com/science/article/abs/pii/S1878875020318489.
[9] Rascón Ramírez FJ, Salazar Asencio OA, Trondin A. Recurrent Agressive Brain Radionecrosis or High-Grade Glioma: How to Treat? Int J Brain Disord Treat. 2019 [citado 12/05/2023];5(1):1-4. Disponible en: https://clinmedjournals.org/articles/ijbdt/international-journal-of-brain-disorders- and-treatment-ijbdt-5-027.php?jid=ijbdt.
[10] Sayan M, Şahin B, Zoto Mustafayev T, Sare Kefelioğlu ES, Vergalasova I, Gupta A, et al. Risk of symptomatic radiation necrosis in patients treated with stereotactic radiosurgery for brain metastases. Neurocirugía. 2021 [citado 12/05/2023];32(6):261-7. Disponible en: https://www.revistaneurocirugia.com/es-risk-symptomatic-radiation- necrosis-in-articulo-S1130147320301111.
[2] Wernicke AG, Taube S, Smith AW, Herskovic A, Parashar B, Schwartz TH. Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control. Brachytherapy. 2020 [citado 12/05/2023];19(5):705-12. Disponible en https://www.sciencedirect.com/science/article/abs/pii/S1538472120301318?via%3D ihub.
[3] Chung C, Bryant A, Brown PD. Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery. Cochrane Database of Systematic Reviews. 2018 [citado 12/05/2023];7(7):CD011492. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513335/.
[4] Raggabi A, Bourazza A, Lalya I. Prise en charge de la radionécrose cérébrale: expérience du Service de Neurologie de l'Hôpital Militaire d'Instruction Mohammed V. Pan Afr Med J. 2019 [citado 12/05/2023];33. Disponible en: https://www.panafrican- med-journal.com/content/article/33/188/full/.
[5] Donovan EK, Parpia S, Greenspoon JN. Incidence of radionecrosis in single-fraction radiosurgery compared with fractionated radiotherapy in the treatment of brain metastasis. Curr Oncol. 2019 [citado 12/05/2023];26(3):e328-e33. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588068/.
[6] Lupattelli M, Alì E, Ingrosso G, Saldi S, Fulcheri C, Borghesi S, et al. Stereotactic Radiotherapy for Brain Metastases: Imaging Tools and Dosimetric Predictive Factors for Radionecrosis. J Pers Med. 2020 [citado 12/05/2023];10(3):59. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565332/pdf/jpm-10-00059.pdf.
[7] Rascón Ramírez FJ, Sallabanda Díaz K, Salazar Ascencio OA, Trondin A, Avecillas Chasín JM. Radionecrosis gigante recurrente imitando un glioma de alto grado: el uso de ácido 5-aminolevulínico como técnica para su diferenciación. Gliomat. 2015 [citado 12/05/2023];1(3):51-3. Disponible en: https://www.researchgate.net/publication/297038197_Radionecrosis_recurrente_imit ando_glioma_de_alto_el_uso_de_5-aminolevulinico_como_tecnica_para_su_diferenciacion.
[8] Erpolat OP, Demircan NV, Sarıbas GS, Kuzucu P, Senturk E, Elmas C, et al. A Comparison of Ramipril and Bevacizumab to Mitigate Radiation-Induced Brain Necrosis: An Experimental Study. World Neurosurg. 2020 [citado 12/05/2023];144:e210-e20. Disponible en:https://www.sciencedirect.com/science/article/abs/pii/S1878875020318489.
[9] Rascón Ramírez FJ, Salazar Asencio OA, Trondin A. Recurrent Agressive Brain Radionecrosis or High-Grade Glioma: How to Treat? Int J Brain Disord Treat. 2019 [citado 12/05/2023];5(1):1-4. Disponible en: https://clinmedjournals.org/articles/ijbdt/international-journal-of-brain-disorders- and-treatment-ijbdt-5-027.php?jid=ijbdt.
[10] Sayan M, Şahin B, Zoto Mustafayev T, Sare Kefelioğlu ES, Vergalasova I, Gupta A, et al. Risk of symptomatic radiation necrosis in patients treated with stereotactic radiosurgery for brain metastases. Neurocirugía. 2021 [citado 12/05/2023];32(6):261-7. Disponible en: https://www.revistaneurocirugia.com/es-risk-symptomatic-radiation- necrosis-in-articulo-S1130147320301111.
Copyright © 2026 Duniel Abreu Casas, Alfredo Daniel Alemán Bacallao, Mercedes Rita Salinas Olivares
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License